US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 5.2600
  • +0.1100+2.14%
Close Dec 13 16:00 ET
  • 5.2600
  • 0.00000.00%
Post 20:01 ET
3.78MMarket Cap-0.69P/E (TTM)

About InMed Pharmaceuticals Company

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around the research and development of small molecule pharmaceuticals drug candidates. The BayMedica segment focuses on the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

Company Profile

SymbolINM
Company NameInMed Pharmaceuticals
Issue Price4.50
Founded1981
CEOMr. Eric A. Adams
MarketNASDAQ
Employees13
Fiscal Year Ends06-30
Address885 West Georgia Street,Suite 1445
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6C 3E8
Phone1-604-669-7207

Company Executives

  • Name
  • Position
  • Salary
  • Eric A. Adams
  • Director, President and Chief Executive Officer
  • 367.57K
  • Michael Woudenberg
  • Chief Operating Officer
  • 297.42K
  • N. Netta Jagpal
  • Chief Financial Officer, Corporate Secretary and Principal Accounting Officer
  • --
  • Dr. Eric C. Hsu, PhD
  • Senior Vice President, Preclinical Research and Development
  • --
  • Alexandra D.J. Mancini
  • Senior Vice President, Clinical and Regulatory Affairs
  • 284.92K
  • Andrew Hull
  • Chairman of the Board
  • 61.10K
  • Nicole Lemerond
  • Independent Director
  • 46.21K
  • Janet Grove
  • Independent Director
  • 48.60K
  • Bryan T. Baldasare
  • Independent Director
  • 48.60K
Heat List
US
Overall
Symbol
Price
% Chg

No Data